Institutional Repository
Thesis Issued 2026-09-09 EN

A Study of the Control of Luteal Function in the Sheep and Goat

Author: Nazim Ahmad

Abstract

This work was undertaken to investigate some of the various factors involved in the control of luteal activity in the sheep and goat. Administration of ACTH immediately prior to the expected time of luteolysis, maintained progesterone secretion, decreased the release of PGF2x and oxytocin, and delayed oestrus. The mechanism appears to involve a reduction in the sensitivity of the uterus to oxytocin, via a reduction in endometrial oxytocin receptors. To examine the significance of testosterone secretion immediately prior to luteolysis, the steroid was administered in the mid-luteal phase, and testosterone synthesis was also blocked with spironolactone. While both treatments had some minor effects on hormone release in sheep, in the goat they were significant. Testosterone administration induced premature luteolysis with release of PGF2 and oxytocin, whereas spironolactone inhibited luteolysis and associated hormone release. It would appear that in the goat, but not in the sheep, testosterone may be a significant precursor for oestrogen synthesis. Physiological doses of progesterone for 15 days were found to stimulate endometrial oxytocin receptors and uterine sensitivity to oxytocin in the goat. Oestradiol was found not to be essential for this effect, and had no similar action, but was found to potentiate the action of progesterone. The release of oxytocin at various times of the ovine oestrous cycle was pulsatile, even just after oestrus. While PGFza, a product of the cycloxygenase pathway of arachidonic acid, has been cited as a major stimulus to the release of luteal oxytocin in sheep, it is possible that the lipoxygenase metabolites may also be involved. Intra-uterine administration of nordihydroguaiaretic acid (NDGA) a 5-liрохygenase inhibitor, delayed luteolysis and this was associated with reductions in luteal oxytocin release, luteal oxytocin content and endometrial oxytocin receptors. Also intraluteal injection of another 5-lipoxygenase inhibitor (BWA4C) reduced both basal and PGFza-stimulated oxytocin release. In vitro studies showed that arachidonic acid could stimulate release of oxytocin; addition the reaction mixture of arachidonic acid and lipoxygenase increasea release further. These effects were blocked by NDGA. However, it is possible that the effect may have been due, at least in part, to а non-physiological disruption of the cell membrane.